NYSE:AVTRLife Sciences
Assessing Avantor (AVTR) Valuation as Class Action Deadline and Downgrade Weigh on Sentiment
Avantor (AVTR) is back in focus as a securities fraud class action deadline approaches, and a recent downgrade from BofA highlights muted backlog conversion, equipment reliability concerns, and tougher competition that are pressuring near term sentiment.
See our latest analysis for Avantor.
The stock has been under steady pressure, with the latest share price at $11.10 and a year-to-date share price return of negative 47.64 percent. The 1-year total shareholder return of negative 47.42...